Table 1.
Sociodemographic and clinical data of hepatocellular carcinoma patients
| n | % | |
|---|---|---|
| Age (years) (Mean±SD) | 60.45±9.54 | |
| Follow-up duration (months) (Mean±SD) | 51.44±6.45 | |
| Sex | ||
| Male | 66 | 77.6 |
| Female | 19 | 22.4 |
| Etiology of HCC | ||
| Hepatitis B | 52 | 61.2 |
| Hepatitis C | 10 | 11.7 |
| Cryptogenic cirrhosis | 14 | 16.5 |
| Alcoholic cirrhosis | 6 | 7.0 |
| Other | 3 | 3.6 |
| Cirrhosis status | ||
| Cirrhotic | 81 | 95.2 |
| Non-cirrhotic | 2 | 2.4 |
| Child classification | ||
| Child A | 49 | 57.6 |
| Child B | 20 | 23.5 |
| Child C | 6 | 7.1 |
| Treatment | ||
| TACE | 29 | 34.1 |
| RFA | 34 | 40.0 |
| Surgical resection | 9 | 10.5 |
| Liver transplantation | 11 | 12.9 |
| Systemic chemotherapy | 11 | 12.9 |
| Other | 18 | 20.9 |
| Number of treatment | ||
| Single treatment | 52 | 61.1 |
| Multiple treatments | 24 | 28.2 |
SD: Standard deviation; HCC: Hepatocellular carcinoma; RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization.